Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
bladder/antikancerogeno
Veza se sprema u međuspremnik
Stranica 1 iz 72 rezultatima
Bladder cancer treatment and methods
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to the treatment of bladder cancer using Apaziquone formulations and methods. The present invention can take advantage of propylene glycol concentrations and/or NAD(P)H:quinone oxidoreductase-1 (NQO1), Cytochrome P450 Oxidoreductase (P450R) and
Bladder cancer treatment and methods
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to the treatment of bladder cancer using Apaziquone formulations and methods. The present invention can take advantage of propylene glycol concentrations and/or NAD(P)H:quinone oxidoreductase-1 (NQO1), Cytochrome P450 Oxidoreductase (P450R) and
Medical compositions for intravesical treatment of bladder cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
Bladder cancer accounts for approximately 2% of all malignant cancers and is the fifth and tenth most common cancer in men and women, respectively. The American Cancer Society estimated that 54,500 new cases and 11,700 deaths would have occurred in 1997. Superficial
Medical compositions for intravesical treatment of bladder cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
Bladder cancer accounts for approximately 2% of all malignant cancers and is the fifth and tenth most common cancer in men and women, respectively. The American Cancer Society estimated that 54,500 new cases and 11,700 deaths would have occurred in 1997. Superficial
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compositions and methods for the instillation of lipid vehicles comprised of liposomes for the treatment of various disorders, including bladder inflammation and dysfunction. The liposomes of the present invention
Method of reducing alopecia and bladder toxicity of cyclophosphamide
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
This invention relates generally to the field of cancer therapy and more particularly to a method for reducing toxicity of cyclophosphamide.
DESCRIPTION OF RELATED ART
Chemotherapy is now a recognized and widely used modality of cancer treatment. Depending upon the type of
Method for localization and therapy of occult bladder cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the diagnosis of cancer. In particular, this invention describes electromotive administration of dye substances into the bladder wall, with and without vasodilatation, for the localisation, or localisation and
Method for treating bladder cancer with a keyhole limpet hemocyanin composition having enhanced anti-tumor activity
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to a keyhole limpet hemocyanin (KLH) composition that has enhanced immunogenic properties, particularly enhanced anti-tumor activity. Specifically, the present invention relates to an immunogenic agent comprised of KLH formulated to contain
Use of garlic extract as both preventive and therapeutic agents for human prostate and bladder cancers
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is relates to new therapeutic applications of garlic extracts containing allicin, diallyl disulfide, trisulfide, etc., and more specifically this application relates to the use of these extracts against human prostate gland and
Use of a panel of urinary cytokines to predict response to BCG therapy for bladder cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of molecular biology, immunology and oncology. More particularly, it concerns diagnostic methods for predicting a response to an immunotherapy.
2. Description of Related Art
More than 70,000
Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
REFERENCE TO SEQUENCE LISTING SUBMITTED AS A COMPLIANT ASCII TEXT FILE (.txt)
Pursuant to the EFS-Web legal framework and 37 CFR .sctn..sctn. 1.821-825 (see MPEP .sctn. 2442.03(a)), a Sequence Listing in the form of an ASCII-compliant text file (entitled "Sequence_Listing_2912919-063001_ST25.txt"
Methods of cancer treatment with 2-(1'H-Indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The presently disclosed invention relates to a method of cancer treatment using 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester ("ITE") or one of its structural analogs. More particularly, the present invention provides a method by administering a therapeutically
Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
CROSS-REFERENCE TO RELATED APPLICATION
This application is a 371 of PCT/EP2008/000928 filed on Feb. 7, 2008, which claims the benefit of European Patent Application No. 07102209.9 filed on Feb. 13, 2007, the contents of each of which are incorporated herein by reference.
FIELD OF THE INVENTION
The
Mixture having antitumor activities
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
SUMMARY OF THE INVENTION
Tice.RTM. substrain BCG is used clinically as an immunotherapeutic agent against superficial bladder cancer. A boiling water extract of this BCG showed antitumor activity against a murine S180 sarcoma model and was fractionated into three fractions, A, B and C, by the use of
Applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention belongs to the field of medicine, relating to the field of antitumor drugs. Specifically to applications of substituent benzyloxy group containing ether compounds for preparing antitumor drugs.
BACKGROUND OF THE INVENTION
The following journals and
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
